PT-141 10 mg — August 2026
Batch: Not visible in supplied copy · PT-141 10 mg
Also supplied as PT141.jpg. Batch match requires confirmation.
Inquiry list 0
Product visualization · Label shown for illustration; your selected dose is recorded in the inquiry.
PT-141 acts on melanocortin receptors in the central nervous system, including pathways involved in sexual desire and arousal.
For laboratory research only. Not for human or veterinary use.
Local delivery in Chiang Mai. Contact us to confirm timing and charges.
PT-141 acts on melanocortin receptors in the central nervous system, including pathways involved in sexual desire and arousal. Its action centers on brain signaling rather than directly increasing blood flow. Bremelanotide has demonstrated improvements in sexual desire in clinical trials involving women with hypoactive sexual desire disorder.
PT-141 activates melanocortin receptors in the central nervous system. Its mechanism centres on brain signalling involved in desire and arousal rather than a direct increase in blood flow.
Check the selected dose before calculating a solution concentration. Use the diluent and storage conditions specified for the material. Record the preparation date, concentration and storage conditions on the vial; the guides below explain preparation, measurement and storage terminology.
Janoshik reports are listed first. Results apply to the tested sample and batch; ask us to match the report to the batch proposed for your inquiry.
Batch: Not visible in supplied copy · PT-141 10 mg
Also supplied as PT141.jpg. Batch match requires confirmation.
PT-141 / Bremelanotide. Melanocortin receptor agonist.
The selector shows the total amount supplied per vial. Quantity is the number of vials requested.
The preparation and storage section links to guides on reconstitution, storage and measurement. Compound background references are listed under Sources.